Life Science Leader I How A New Biopharma CEO Approaches Diversity & Inclusion

By Rob Wright Michael McCullar, Ph.D., who joined OnQuality Pharmaceuticals as the company’s CEO in Dec. 2020, shares thoughts on his approach to diversity and inclusion (D&I) as a newly appointed leader. The full executive virtual roundtable, “Making Diversity & Inclusion A Best Business Practice,” can be viewed here.